Corvus Pharmaceuticals Inc (CRVS)
1.61
+0.06
(+3.87%)
USD |
NASDAQ |
May 01, 16:00
1.64
+0.03
(+1.86%)
After-Hours: 20:00
Corvus Pharmaceuticals Total Assets (Quarterly): 45.55M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.55M |
| September 30, 2023 | 51.94M |
| June 30, 2023 | 58.04M |
| March 31, 2023 | 58.20M |
| December 31, 2022 | 68.24M |
| September 30, 2022 | 80.35M |
| June 30, 2022 | 92.54M |
| March 31, 2022 | 101.29M |
| December 31, 2021 | 109.46M |
| September 30, 2021 | 119.32M |
| June 30, 2021 | 109.39M |
| March 31, 2021 | 109.24M |
| December 31, 2020 | 85.53M |
| September 30, 2020 | 55.86M |
| June 30, 2020 | 64.18M |
| March 31, 2020 | 73.80M |
| December 31, 2019 | 83.65M |
| Date | Value |
|---|---|
| September 30, 2019 | 92.47M |
| June 30, 2019 | 103.12M |
| March 31, 2019 | 112.31M |
| December 31, 2018 | 118.23M |
| September 30, 2018 | 127.22M |
| June 30, 2018 | 137.92M |
| March 31, 2018 | 148.69M |
| December 31, 2017 | 94.78M |
| September 30, 2017 | 104.79M |
| June 30, 2017 | 115.49M |
| March 31, 2017 | 127.10M |
| December 31, 2016 | 140.15M |
| September 30, 2016 | 149.76M |
| June 30, 2016 | 156.92M |
| March 31, 2016 | 157.22M |
| December 31, 2015 | 98.46M |
| September 30, 2015 | 101.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.55M
Minimum
Dec 2023
119.32M
Maximum
Sep 2021
82.22M
Average
83.65M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.805M |
| Arbutus Biopharma Corp | 144.40M |
| Oragenics Inc | 4.966M |
| Relmada Therapeutics Inc | 97.55M |
| MAIA Biotechnology Inc | 7.567M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.869M |
| Shareholders Equity (Quarterly) | 38.68M |